These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18533092)

  • 1. Misfolding of the prion protein: linking biophysical and biological approaches.
    Noinville S; Chich JF; Rezaei H
    Vet Res; 2008; 39(4):48. PubMed ID: 18533092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural factors underlying the species barrier and susceptibility to infection in prion disease.
    Sweeting B; Khan MQ; Chakrabartty A; Pai EF
    Biochem Cell Biol; 2010 Apr; 88(2):195-202. PubMed ID: 20453922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misfolding dynamics of human prion protein.
    Zaman MH
    Mol Cell Biomech; 2005 Dec; 2(4):179-90. PubMed ID: 16705864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating the conformation of prion protein through ligand binding.
    Yamamoto N; Kuwata K
    J Phys Chem B; 2009 Oct; 113(39):12853-6. PubMed ID: 19725511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate evolution of prion protein domains and the distinct origin of Doppel- and prion-related loci revealed by fish-to-mammal comparisons.
    Rivera-Milla E; Oidtmann B; Panagiotidis CH; Baier M; Sklaviadis T; Hoffmann R; Zhou Y; Solis GP; Stuermer CA; Málaga-Trillo E
    FASEB J; 2006 Feb; 20(2):317-9. PubMed ID: 16352647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein misfolding and prion diseases.
    Cohen FE
    J Mol Biol; 1999 Oct; 293(2):313-20. PubMed ID: 10550211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
    Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
    J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein misfolding and neurodegeneration.
    Soto C; Estrada LD
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, dynamics, and stability of assemblies of the human prion fragment SNQNNF.
    De Simone A; Pedone C; Vitagliano L
    Biochem Biophys Res Commun; 2008 Feb; 366(3):800-6. PubMed ID: 18082625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational changes and development of proteinase K resistance in surface-immobilized PrP.
    Leclerc E; Vetter S
    Arch Virol; 2008; 153(4):683-91. PubMed ID: 18278426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prion proteins: folding and aggregation properties].
    Bousset L; Melki R
    Med Sci (Paris); 2005; 21(6-7):634-40. PubMed ID: 15985207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydrogen/deuterium exchange and disulfide linkage.
    Eghiaian F; Daubenfeld T; Quenet Y; van Audenhaege M; Bouin AP; van der Rest G; Grosclaude J; Rezaei H
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7414-9. PubMed ID: 17442756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water molecules as structural determinants among prions of low sequence identity.
    De Simone A; Dodson GG; Fraternali F; Zagari A
    FEBS Lett; 2006 May; 580(10):2488-94. PubMed ID: 16638576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of protein misfolding in disease.
    Małolepsza EB
    Methods Mol Biol; 2008; 443():297-330. PubMed ID: 18446294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology of the prion protein.
    Linden R; Martins VR; Prado MA; Cammarota M; Izquierdo I; Brentani RR
    Physiol Rev; 2008 Apr; 88(2):673-728. PubMed ID: 18391177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.